Table 1.
Patient | Age | Sex | Anti-TG2-IgA (IU/mL) | Marsh |
---|---|---|---|---|
1 | 14 | m | 200 | 3a |
2 | 7 | m | 200 | 3a |
3 | 5 | f | 134 | 3a |
4 | 3 | m | 200 | 3a |
5 | 16 | f | 200 | 3a-b |
6 | 10 | m | 200 | 3a-b |
Patient | Age | Sex | Anti-TG2-IgA (IU/mL) | Marsh |
---|---|---|---|---|
1 | 14 | m | 200 | 3a |
2 | 7 | m | 200 | 3a |
3 | 5 | f | 134 | 3a |
4 | 3 | m | 200 | 3a |
5 | 16 | f | 200 | 3a-b |
6 | 10 | m | 200 | 3a-b |